The HIF-1α–Mitochondria Axis in Alzheimer's Disease: Therapeutic Potential of Roxadustat in Restoring Neuronal Bioenergetics and Cognitive Function
Although direct evidence in AD remains limited, targeting HIF-1α-mediated mitochondrial adaptation represents a promising approach that may complement existing therapies and warrants further preclinical and clinical investigation.